The now multibillion dollar industry just in the Columbus area has had a presence in the region for the last decade.

Ian King says Cathie Wood's recent $46 million bet on biotech is just the tip of the iceberg as AI starts transforming this ...

The US biotechnology sector has been in a downturn since early 2022, with few signs of a rebound. The S&P Biotech ETF, or XBI ...

Epicrispr Biotechnologies CEO Amber Salzman, Ph.D. offers up four imperatives for industry leaders working to develop ...

As the Houston region positions itself to become a national hub for pharmaceutical manufacturing, San Jacinto College is ...

Members of the National Security Commission on Emerging Biotechnology (NSCEB) met with U.S. Senator Tammy Duckworth Friday to discuss biotechnology innovation.

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy. A full transcript is below. This ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...